Skip to main content
Explore URMC



Faculty and Speakers

We are hosting an international two-day meeting from March 3-5, 2016 (to take place after the APHL Newborn Screening and Genetic Testing Symposium in 2016 in St. Louis) that will bring together experts in newborn screening, pediatrics, and neuromuscular disease as well as other public health stakeholders to review key topics in newborn screening for Pompe disease (already included in the Recommended Universal Screening Panel) and Duchenne muscular dystrophy (DMD) where pilot screening has already begun in the US. 

The primary goal of this meeting will be addressing the components of 1) laboratory screening and 2) short- and long-term clinical follow-up needed to ensure improved health outcomes in Pompe disease and DMD.   We will also discuss how these programs can be implemented to efficiently collect information about the public health and societal impact of population-based neuromuscular screening programs.

Steering / Planning Committee


Faculty / Speakers


Register for this event!